Advertisement intended for health care professionals

l

T/myeloid AML - 3.

T/myeloid AML - 3.
#00001198
 
Author:  John Lazarchick; Brian Davis;
Category:  Myeloid Neoplasms and acute leukemia (WHO 2016) > Acute leukemias of ambiguous lineage
Published Date:  09/28/2011

Because of the dual surface expression of myeloid (CD33 and CD117) and T-cell antigens (CD7 and CD5), cytoplasmic markers were assessed by flow cytometry. The blasts had coexpression of both CD3 and myeloperoxidase (MPO).

Advertisement intended for health care professionals